Insider · CIK 0001107158
Natale S Ricciardi
Files at RPID (RAPID MICRO BIOSYSTEMS, INC.). First filing -, latest -.
Natale S Ricciardi files SEC Form 4 as director at RPID (RAPID MICRO BIOSYSTEMS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Natale S Ricciardi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | RPID RAPID MICRO BIOSYSTEMS, INC. | MOption exercise Class A Common Stock | +842 | $0.75 | $632 | 29,442 | Mar 2, 2026 |
| Feb 27, 2026 | RPID RAPID MICRO BIOSYSTEMS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -842 | $0.75 | $632 | 0 | Mar 2, 2026 |
| May 22, 2025 | RPID RAPID MICRO BIOSYSTEMS, INC. | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 28,600 | May 27, 2025 |
| May 22, 2025 | RPID RAPID MICRO BIOSYSTEMS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
Questions about Natale S Ricciardi
Answered from the filings on this page, as of the latest one.
Is Natale S Ricciardi buying or selling?
Natale S Ricciardi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Natale S Ricciardi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Natale S Ricciardi has 0.
Where does Natale S Ricciardi file Form 4?
Natale S Ricciardi has filed Form 4 at RPID (RAPID MICRO BIOSYSTEMS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.